|
Model Number TET1515 |
Device Problems
Migration or Expulsion of Device (1395); Adverse Event Without Identified Device or Use Problem (2993); Patient Device Interaction Problem (4001)
|
Patient Problems
Corneal Pannus (1447); Adhesion(s) (1695); Purulent Discharge (1812); Foreign Body Reaction (1868); Hematoma (1884); Hemorrhage/Bleeding (1888); Unspecified Infection (1930); Muscle Weakness (1967); Necrosis (1971); Pain (1994); Scar Tissue (2060); Hernia (2240); Impaired Healing (2378); Fluid Discharge (2686); Unspecified Tissue Injury (4559); Appropriate Clinical Signs, Symptoms, Conditions Term / Code Not Available (4581)
|
Event Type
Injury
|
Manufacturer Narrative
|
If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
The patient¿s attorney alleged a deficiency against the device.The product was used for therapeutic treatment of an incisional hernia.It was reported that after implant, the patient experienced infected mesh, infection, scarring, hernia recurrence, hematoma, wound with persistent drainage, open wound, adhesions, necrotic tissue, granulation tissue, foreign body infection, unincorporated mesh, free floating mesh, purulent material, pannus, open tunnel tracts, sinus tract, pain, diastasis, and oozing.Post-operative patient treatment included revision surgery, wound exploration, excision of mesh, cholecystectomy, debridement of wound, incision and drainage of wound, scar revision, primary repair of hernia, evacuation of hematoma, wound packed with antibiotic containing gauze, granulation tissue debrided, necrotic tissue removed, piece of lower abdominal skin removed, scar revision, pain medication, wounds irrigated with antibiotic solution, and cauterized/coagulation of oozing.
|
|
Event Description
|
The patient¿s attorney alleged a deficiency against the device.The product was used for therapeutic treatment of an incisional hernia.It was reported that after implant, the patient experienced infected mesh, infection, scarring, hernia recurrence, hematoma, wound with persistent drainage, open wound, adhesions, necrotic tissue, granulation tissue, foreign body infection, unincorporated mesh, free floating mesh, purulent material, pannus, open tunnel tracts, sinus tract, pain, diastasis, and oozing.Post-operative patient treatment included revision surgery, wound exploration, excision of mesh, cholecystectomy, debridement of wound, incision and drainage of wound, scar revision, primary repair of hernia, evacuation of hematoma, wound packed with antibiotic containing gauze, granulation tissue debrided, excision of sinus tract, necrotic tissue removed, piece of lower abdominal skin removed, scar revision, pain medication, wounds irrigated with antibiotic solution, and cauterized/coagulation of oozing.
|
|
Manufacturer Narrative
|
Additional information: b5, d8, e1 (facility name, street 1, city, region, postal code, g1 (mfr contact first name, last name, street 1, mfr city, region, country code, postal code, email, phone number), g3, h6 medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Search Alerts/Recalls
|
|
|